Informe sobre el tamaño, el alcance y las previsiones del mercado de oncología intervencionista</font></font>

Name: Mercado de oncología intervencionista por producto (radiofrecuencia, microondas, embolización, guías), por procedimiento (ablación térmica, no térmica, TACE, TARE, TAE), por cáncer (hígado, pulmón, riñón, metástasis ósea), por usuario final (hospital, centro de cirugía ambulatoria) y región (Norteamérica, Europa, Asia Pacífico, Sudamérica, Oriente Medio y África), tendencias globales y pronóstico de 2022 a 2029
Price: 3499 USD
Availability: InStock
Rating: 4.5 (99 reviews)
Author: Exactitude Consultancy
ISBN: 6255

Panorama del mercado de la oncología intervencionista

Se espera que el mercado mundial de oncología intervencionista crezca a una tasa anual compuesta del 6,7 % entre 2022 y 2029. Se espera que alcance más de 3350 millones de dólares en 2029, frente a los 1900 millones de dólares de 2020.

La oncología intervencionista abarca un espectro de prácticas médicas que implican el diagnóstico, el tratamiento y los cuidados paliativos del cáncer mediante procedimientos mínimamente invasivos realizados con guía por imágenes. Se prevé que la creciente incidencia del cáncer en la población y la consiguiente presión sobre los recursos sanitarios atribuible a estas enfermedades impulsen la demanda de metodologías y estrategias innovadoras de oncología intervencionista para el manejo de la enfermedad .

Por ejemplo, en junio de 2023, los datos publicados por los Centros para el Control y la Prevención de Enfermedades (CDC) de EE. UU. indicaron 1.603.844 nuevos casos de cáncer y 602.347 muertes relacionadas con el cáncer en EE. UU. durante 2020. Además, un aumento en los diagnósticos de cáncer y un mayor esfuerzo de investigación entre las partes interesadas de la industria destinado a desarrollar nuevas terapias para diversos tipos de cáncer están preparados para catalizar el crecimiento en el mercado mundial de oncología intervencionista durante el período de pronóstico.

ATRIBUTO	DETALLES
Periodo de estudio	2020-2029
Año base	2021
Año estimado	2022
Año pronosticado	2022-2029
Periodo histórico	2018-2020
Unidad	Valor (miles de millones de USD), (Miles de unidades)
Segmentación	Por producto, por procedimiento, por cáncer, por usuario final, por región
Por producto	Frecuencia de radio Microonda Embolización Alambres guía
Por procedimiento	Térmico Ablación no térmica TACE TARA TAE
Por cáncer	Hígado Pulmón Riñón Metástasis ósea
Por el usuario final	Hospitales ASC Academia
Por región	Asia Pacífico América del norte Ministerio de Asuntos Exteriores Sudamerica Europa

Además, el mercado mundial de oncología intervencionista experimentó una desaceleración en su trayectoria de crecimiento debido a la pandemia de COVID-19. Esta disminución se precipitó por las medidas de confinamiento gubernamentales, que llevaron al aplazamiento o cancelación de tratamientos oncológicos y, en consecuencia, a la reducción de las visitas de los pacientes a hospitales y clínicas. En los últimos años, ha habido un aumento notable de la demanda de procedimientos mínimamente invasivos debido a sus ventajas inherentes sobre las modalidades de tratamiento tradicionales.

Entre los principales beneficios se incluyen la disminución de las complicaciones operatorias, estancias hospitalarias más cortas, reducción de las molestias posoperatorias, incisiones más pequeñas que producen beneficios estéticos, menor riesgo de infección y períodos de recuperación más rápidos. Estos procedimientos aprovechan tecnologías avanzadas para el diagnóstico y tratamiento de diversas enfermedades, incluido el cáncer, ofreciendo un medio pragmático de extirpación de tumores y extracción de ganglios linfáticos con mínimas cicatrices. Además, las técnicas mínimamente invasivas facilitan la biopsia de tejidos y los estudios de estadificación precisos, lo que aumenta la precisión del diagnóstico y la eficacia del tratamiento.

[título id="attachment_9525" align="alignleft" width="870"]

Interventional Oncology Market | Exactitude Consultancy

Mercado de Oncología Intervencionista | Exactitude Consultancy[/subtítulo]

Frequently Asked Questions

• What is the worth of the global Interventional Oncology market?

The Interventional Oncology market size had crossed USD 1.9 billion in 2020 and will observe a CAGR of more than % up to 2029 driven by the rising technological advancements.

• What is the size of the North America Interventional Oncology industry?

North America held more than 35% of the Interventional Oncology market revenue share in 2021 and will witness expansion. In 2020, the worldwide interventional oncology market was headed by Boston Scientific (US). To expand its market presence and product offerings, the firm primarily relies on growth techniques such as acquisitions and expansions. The company's acquisition of BTG will help it grow its chemoembolization, radioembolization, and ablation therapy options. Boston Scientific seeks to get regulatory and reimbursement approvals on a regular basis. By increasing its position in the global healthcare sector, the firm invests in fast-growing areas as well as new markets as part of its long-term growth plan.

• What are the drivers, restraints and opportunities for the Interventional Oncology market, globally?

One of the drivers of interventional oncology is rising patient preference for minimally invasive procedures. One of the restraints of the interventional oncology market is the dearth of well trained and skilled radiologists and oncologists. One of the biggest opportunities in the interventional oncology market are the emerging economies which offer high growth potential.

• Which are the top companies to hold the market share in the Interventional Oncology market?

Medtronic, Boston Scientific, BD, Terumo, Merit Medical, Angio Dynamics, J&J, Teleflex, Cook Medical, HealthTronics, MedWaves, Sanarus, IMBiotechnologies, Trod Medical, IceCure Medical, Mermaid Medicals, Interface Biomaterials BV, Guerbet, ABK Biomedical are the key players in the interventional oncology market.

• Which is the largest regional market for Interventional Oncology market?

North America, followed by Europe, was the largest regional component of the entire market in 2020. The high incidence of chronic illnesses, expanding geriatric population, increasing use of minimally invasive treatments, and the presence of significant companies in the region all contribute to the region's big market share.

• Which region is expected to experience the greatest CAGR during the forecast period?

With a CAGR of 9.6% over the projection period, Asia Pacific is the fastest-growing regional category in the interventional oncology market. The APAC interventional oncology market is growing due to rising healthcare expenditure, an increase in the number of hospitals and CROs in India and China, an expanding research base in India, China, and Japan, government efforts to increase funding, and supportive regulations for the development and commercialization of advanced interventional oncology products.

Interventional Oncology Market Segment Analysis

The Interventional Oncology market is divided on the basis of Product into Radiofrequency, Microwave, embolization, guidewires. Embolization devices will account for a portion of the interventional oncology market in 2020. Non-radioactive embolic agents and radioembolic agents are examples of embolic devices. Although these devices were originally developed to treat hepatocellular carcinoma, they have since been widely used to treat a variety of other cancers. These devices are utilised when ablation procedures cannot be used to treat tumours or when the tumour size is considerable. They're also employed in palliative operations and as a pre-operative therapy to help with liver resection outcomes. On the basis of type of Procedure, it can be divided into Thermal, Non-Thermal Ablation, TACE, TARE, TAE. On the basis of cancer, this market is divided into liver, lung, kidney, bone metastasis. In 2020, liver cancer had the biggest proportion of the interventional oncology market. Interventional oncology is important in the treatment of liver cancer because surgical removal of the tumour may not leave the tissue healthy enough for the liver to function properly. Thus, interventional oncology techniques can successfully treat primary liver tumours or liver tumours caused by metastatic malignancies. As a result, interventional oncology is used in more than half of all primary and metastatic liver cancer therapies. On the basis of end-user, it can be categorized into hospital, ASC.

[caption id="attachment_9528" align="alignleft" width="680"]

Interventional Oncology Market | Exactitude Consultancy[/caption]

Interventional Oncology Market Players

Medtronic, Boston Scientific, BD, Terumo, Merit Medical, Angio Dynamics, J&J, Teleflex, Cook Medical, HealthTronics, MedWaves, Sanarus, IMBiotechnologies, Trod Medical, IceCure Medical, Mermaid Medicals, Interface Biomaterials BV, Guerbet, ABK Biomedical are the key players in the interventional oncology market.

Who Should Buy? Or Key Stakeholders

Hospitals
Clinics
Government Healthcare organisations
Government healthcare departments
Information technology companies
Others

Key Takeaways

The global interventional oncology market is expected to grow at 6.7% CAGR.
On the basis of Product, embolization devices will account for a portion of the interventional oncology market.
On the basis of type of procedure, it can be divided into Thermal, Non-Thermal Ablation, TACE, TARE, TAE.
On the basis of cancer, liver cancer had the biggest proportion of the interventional oncology market.
North America dominated the market in the regional share.
The integration of minimally invasive techniques like radiofrequency ablation and embolization therapies is a major trend in the interventional oncology market, offering precise tumor targeting and reduced patient recovery times.

Interventional Oncology Market Regional Analysis

The Interventional Oncology market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

[caption id="attachment_9529" align="alignleft" width="680"]

Interventional Oncology Market | Exactitude Consultancy[/caption]

Key Market Segments: Interventional Oncology Market

Interventional Oncology Market by Product, 2020-2029, (USD Million)

Radiofrequency
Microwave
Embolization
Guidewires

Interventional Oncology Market by Procedure, 2020-2029, (USD Million)

Thermal
Non-Thermal Ablation
TACE
TARE
TAE

Interventional Oncology Market by Cancer, 2020-2029, (USD Million)

Liver
Lung
Kidney
Bone Metastasis

Interventional Oncology Market by End User, 2020-2029, (USD Million)

Hospital
ASC

Interventional Oncology Market by Region, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important countries in all regions are covered.

Key Question Answered

What is the current size of the Interventional Oncology market?
What are the key factors influencing the growth of Interventional Oncology?
What are the major applications for Interventional Oncology?
Who are the major key players in the Interventional Oncology market?
Which region will provide more business opportunities for Interventional Oncology in future?
Which segment holds the maximum share of the Interventional Oncology market?

Introducción
1. Definición de mercado
2. Segmentación del mercado
3. Cronología de la investigación
4. Supuestos y limitaciones

Metodología de la investigación
1. Minería de datos
  1. Investigación secundaria
  2. Investigación primaria
  3. Asesoramiento de expertos en la materia
2. Controles de calidad
  1. Revisión final
3. Triangulación de datos
  1. Enfoque de abajo hacia arriba
  2. Enfoque de arriba hacia abajo
  3. Flujo de investigación
4. Fuentes de datos

Resumen ejecutivo

Descripción general del mercado
1. Perspectivas del mercado mundial de oncología intervencionista
  1. Factores impulsores del mercado
  2. Restricciones del mercado
  3. Oportunidades de mercado
2. Impacto de la COVID-19 en el mercado mundial de oncología intervencionista

Mercado mundial de oncología intervencionista por producto (millones de USD)
1. Frecuencia de radio
2. Microonda
3. Embolización
4. Alambres guía

Mercado mundial de oncología intervencionista por procedimiento (millones de USD)
1. Térmico
2. Ablación no térmica
3. TACE
4. TARA
5. TAE

Mercado mundial de oncología intervencionista por cáncer (millones de USD)
1. Hígado
2. Pulmón
3. Riñón
4. Metástasis ósea

Mercado mundial de oncología intervencionista por usuario final (millones de USD)
1. Hospital
2. CSA

Mercado mundial de oncología intervencionista por región (millones de USD)
1. Introducción
2. Asia-Pacífico
  1. Porcelana
  2. India
  3. Japón
  4. Corea del Sur
  5. Australia
  6. Sudeste asiático
  7. Resto de Asia-Pacífico
3. América del norte
  1. Estados Unidos
  2. Canadá
  3. México
4. Europa
  1. Alemania
  2. Reino Unido
  3. Francia
  4. Italia
  5. España
  6. Rusia
  7. Resto de Europa
5. Sudamerica
  1. Brasil
  2. Argentina
  3. Colombia
  4. Resto de Sudamérica
6. Oriente Medio y África
  1. Emiratos Árabes Unidos
  2. Arabia Saudita
  3. Sudáfrica
  4. Resto de Oriente Medio y África

Perfiles de empresas* (descripción general de la empresa, descripción general de la empresa, productos ofrecidos, desarrollos recientes)

1. Medtronic
2. Científico de Boston
3. Terumo
4. Mérito médico
5. Dinámica angiográfica
6. J&J
7. Teleflex
8. Cocinero médico
9. SaludTronics
10. Ondas médicas

*La lista de empresas es orientativa

LISTA DE TABLAS

TABLE 1          GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 2          GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 3          GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 4          GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 5          US INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 6          US INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 7          US INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 8          US INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 9          CANADA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 10        CANADA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 11        CANADA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 12        CANADA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 13        MEXICO INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 14        MEXICO INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 15        MEXICO INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 16        MEXICO INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 17        BRAZIL INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 18        BRAZIL INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 19        BRAZIL INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 20        BRAZIL INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 21        ARGENTINA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 22        ARGENTINA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 23        ARGENTINA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 24        ARGENTINA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 25        COLOMBIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 26        COLOMBIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 27        COLOMBIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 28        COLOMBIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 29        REST OF SOUTH AMERICA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 30        REST OF SOUTH AMERICA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 31        REST OF SOUTH AMERICA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 32        REST OF SOUTH AMERICA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 33        INDIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 34        INDIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 35        INDIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 36        INDIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 37        CHINA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 38        CHINA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 39        CHINA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 40        CHINA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 41        JAPAN INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 42        JAPAN INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 43        JAPAN INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 44        JAPAN INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 45        SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 46        SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 47        SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 48        SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 49        AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 50        AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 51        AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 52        AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 53        SOUTH-EAST ASIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 54        SOUTH-EAST ASIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 55        SOUTH-EAST ASIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 56        SOUTH-EAST ASIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 57        REST OF ASIA PACIFIC INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 58        REST OF ASIA PACIFIC INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 59        REST OF ASIA PACIFIC INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 60        REST OF ASIA PACIFIC INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 61        GERMANY INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 62        GERMANY INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 63        GERMANY INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 64        GERMANY INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 65        UK INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 66        UK INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 67        UK INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 68        UK INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 69        FRANCE INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 70        FRANCE INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 71        FRANCE INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 72        FRANCE INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 73        ITALY INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 74        ITALY INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 75        ITALY INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 76        ITALY INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 77        SPAIN INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 78        SPAIN INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 79        SPAIN INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 80        SPAIN INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 81        RUSSIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 82        RUSSIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 83        RUSSIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 84        RUSSIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 85        REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 86        REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 87        REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 88        REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 89        UAE INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 90        UAE INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 91        UAE INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 92        UAE INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 93        SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 94        SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 95        SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 96        SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 97        SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 98        SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 99        SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 100      SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

TABLE 101      REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 102      REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 103      REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029

TABLE 104      REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029

LIST OF FIGURES

FIGURE 1             MARKET DYNAMICS

FIGURE 2             MARKET SEGMENTATION

FIGURE 3             REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4             DATA TRIANGULATION

FIGURE 5             BOTTOM-UP APPROACH

FIGURE 6             TOP-DOWN APPROACH

FIGURE 7             RESEARCH FLOW

FIGURE 8             GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE, USD MILLION, 2019-2028

FIGURE 9             GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY END USER, USD MILLION, 2019-2028

FIGURE 10           GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT, USD MILLION, 2019-2028

FIGURE 11           GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY CANCER, USD MILLION, 2019-2028

FIGURE 12           GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY REGION, USD MILLION, 2019-2028

FIGURE 13           PORTER’S FIVE FORCES MODEL

FIGURE 14           GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE, 2020

FIGURE 15           GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY END USER 2020

FIGURE 16           GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT 2020

FIGURE 17           GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY CANCER 2020

FIGURE 18           INTERVENTIONAL ONCOLOGY MARKET BY REGION 2020

FIGURE 19           MARKET SHARE ANALYSIS

FIGURE 20           MEDTRONIC: COMPANY SNAPSHOT

FIGURE 21           BOSTON SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 22           TERUMO: COMPANY SNAPSHOT

FIGURE 23           MERIT MEDICAL: COMPANY SNAPSHOT

FIGURE 24           ANGIO DYNAMICS: COMPANY SNAPSHOT

FIGURE 25           J&J: COMPANY SNAPSHOT

FIGURE 26           TELEFLEX: COMPANY SNAPSHOT

FIGURE 27           COOK MEDICAL: COMPANY SNAPSHOT

FIGURE 28           HEALTHTRONICS: COMPANY SNAPSHOT

FIGURE 29           MEDWAVES: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Interventional Oncology Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

Instant access to hundreds of data points and trends

Panorama del mercado de la oncología intervencionista

Frequently Asked Questions

• What is the worth of the global Interventional Oncology market?

• What is the size of the North America Interventional Oncology industry?

• What are the drivers, restraints and opportunities for the Interventional Oncology market, globally?

• Which are the top companies to hold the market share in the Interventional Oncology market?

• Which is the largest regional market for Interventional Oncology market?

• Which region is expected to experience the greatest CAGR during the forecast period?

Interventional Oncology Market Segment Analysis

Interventional Oncology Market Players

Who Should Buy? Or Key Stakeholders

Key Takeaways

Interventional Oncology Market Regional Analysis

Key Market Segments: Interventional Oncology Market

Key Question Answered

LISTA DE TABLAS

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept